BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  Biohaven Reports Recent Business Developments and First Quarter 2026 Financial Results

  May 4, 2026

   · 

  13 min read
• Press Releases

  Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference

  May 4, 2026

   · 

  1 min read
• Press Releases

  Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 4, 2026

  May 4, 2026

   · 

  2 min read
• Press Releases

  Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 4, 2026

  May 4, 2026

   · 

  2 min read
• Press Releases

  Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 4, 2026

  May 4, 2026

   · 

  1 min read
• Press Releases

  CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

  May 4, 2026

   · 

  18 min read
• Press Releases

  Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program

  May 4, 2026

   · 

  5 min read
• Press Releases

  CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

  May 4, 2026

   · 

  3 min read
• Press Releases

  BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026

  May 4, 2026

   · 

  3 min read
• Press Releases

  Viatris Announces Chief Financial Officer Transition

  May 4, 2026

   · 

  4 min read